US › Healthcare

Universe Pharmaceuticals Inc (UPC)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$7.05+8.80%

Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue

$9.0M

Revenue YoY

-34.7%

Net profit

$-1.6M

Profit YoY

+71.5%

EPS

$-9.44

EPS estimate

$0.00

Net margin

-17.2%

Key statistics

Market cap

$2.1M

Forward P/E

0.0

P/B

0.04

Book value

$99.64

EPS (TTM)

$-1.38

52-week high

$17.96

52-week low

$2.00

50-day MA

$3.97

200-day MA

$3.69

Beta

1.46

Shareholding

Insiders

11.38%

Institutions

4.45%

Largest institutional holders

Fund	Stake
UBS Group AG	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Universe Pharmaceuticals Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.